Search

everythinglearnresearchcommunity

for

Search:↓

A new compound, HTPI, promotes hair growth by protecting cells from damage and regulating energy use.

Baricitinib is effective and safe for treating severe alopecia areata.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Cyclosporin A and FK506 can start new hair growth without needing immunosuppression.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Inhibiting PDE8A may help treat hair loss by boosting fat cell growth and hair regeneration.

A JAK1 variant causes hair loss, skin issues, and thyroid disease, but treatment with a specific inhibitor can help.

CMX from Centipeda minima can significantly improve hair growth in mild to moderate balding.

Pix Liquida may help treat alopecia areata.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

Calcineurin inhibitors, used in kidney transplants, can cause a wide range of side effects including kidney damage and other health issues.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.